MIRA Pharmaceuticals, Inc Common Stock
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -2,081 | -1,730 | -1,768 |
EBITDA | -2,081 | -1,730 | -1,768 |
EBIT | -4,163 | -3,461 | -3,536 |
Net Income | -2,043 | -1,691 | -1,717 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -1,842 | -863 | -1,049 |
Cash | 4,144 | 2,823 | 3,528 |
Basic Shares | 15,071 | 14,780 | 19,707 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -8,526 | ||
EBITDA | -3,456 | -7,047 | -2,152 |
EBIT | -11,982 | -7,047 | -2,152 |
Net Income | -11,982 | -7,058 | -2,176 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -4 | -5,604 | -1,376 |
Cash | 4,602 | 350 | 2,809 |
Basic Shares | 18,566 | 14,745 | 14,745 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.14 |
2024-06-30 | -$0.11 |
2024-03-31 | -$0.12 |
2023-12-31 | -$0.39 |
